Kepley CL - Search Results

1

Inhibition of inflammatory arthritis using fullerene nanomaterials.

Dellinger AL, Cunin P, Lee D, Kung AL, Brooks DB, Zhou Z, Nigrovic PA, Kepley CL. Dellinger AL, et al. Among authors: kepley cl. PLoS One. 2015 Apr 16;10(4):e0126290. doi: 10.1371/journal.pone.0126290. eCollection 2015. PLoS One. 2015. PMID: 25879437 Free PMC article.

2

Fullerene nanomaterials potentiate hair growth.

Zhou Z, Lenk R, Dellinger A, MacFarland D, Kumar K, Wilson SR, Kepley CL. Zhou Z, et al. Among authors: kepley cl. Nanomedicine. 2009 Jun;5(2):202-7. doi: 10.1016/j.nano.2008.09.005. Epub 2009 Feb 14. Nanomedicine. 2009. PMID: 19223242

3

Fullerene nanomaterials inhibit phorbol myristate acetate-induced inflammation.

Dellinger A, Zhou Z, Lenk R, MacFarland D, Kepley CL. Dellinger A, et al. Among authors: kepley cl. Exp Dermatol. 2009 Dec;18(12):1079-81. doi: 10.1111/j.1600-0625.2009.00904.x. Exp Dermatol. 2009. PMID: 19555428 Free PMC article.

4

A steroid-mimicking nanomaterial that mediates inhibition of human lung mast cell responses.

Dellinger AL, Zhou Z, Kepley CL. Dellinger AL, et al. Among authors: kepley cl. Nanomedicine. 2014 Aug;10(6):1185-93. doi: 10.1016/j.nano.2014.02.006. Epub 2014 Feb 22. Nanomedicine. 2014. PMID: 24566277 Free PMC article.

5

C5a receptor enables participation of mast cells in immune complex arthritis independently of Fcγ receptor modulation.

Nigrovic PA, Malbec O, Lu B, Markiewski MM, Kepley C, Gerard N, Gerard C, Daëron M, Lee DM. Nigrovic PA, et al. Arthritis Rheum. 2010 Nov;62(11):3322-33. doi: 10.1002/art.27659. Arthritis Rheum. 2010. PMID: 20662064 Free PMC article.

6

Uptake and distribution of fullerenes in human mast cells.

Dellinger A, Zhou Z, Norton SK, Lenk R, Conrad D, Kepley CL. Dellinger A, et al. Among authors: kepley cl. Nanomedicine. 2010 Aug;6(4):575-82. doi: 10.1016/j.nano.2010.01.008. Epub 2010 Feb 4. Nanomedicine. 2010. PMID: 20138243 Free PMC article.

7

A new class of human mast cell and peripheral blood basophil stabilizers that differentially control allergic mediator release.

Norton SK, Dellinger A, Zhou Z, Lenk R, Macfarland D, Vonakis B, Conrad D, Kepley CL. Norton SK, et al. Among authors: kepley cl. Clin Transl Sci. 2010 Aug;3(4):158-69. doi: 10.1111/j.1752-8062.2010.00212.x. Clin Transl Sci. 2010. PMID: 20718816 Free PMC article.

8

Liposomal formulation of amphiphilic fullerene antioxidants.

Zhou Z, Lenk RP, Dellinger A, Wilson SR, Sadler R, Kepley CL. Zhou Z, et al. Among authors: kepley cl. Bioconjug Chem. 2010 Sep 15;21(9):1656-61. doi: 10.1021/bc1001664. Bioconjug Chem. 2010. PMID: 20839887 Free PMC article.

9

A novel class of compounds with cutaneous wound healing properties.

Zhou Z, Joslin S, Dellinger A, Ehrich M, Brooks B, Ren Q, Rodeck U, Lenk R, Kepley CL. Zhou Z, et al. Among authors: kepley cl. J Biomed Nanotechnol. 2010 Oct;6(5):605-11. doi: 10.1166/jbn.2010.1157. J Biomed Nanotechnol. 2010. PMID: 21329053

10

Epoxyeicosatrienoic acids are involved in the C(70) fullerene derivative-induced control of allergic asthma.

Norton SK, Wijesinghe DS, Dellinger A, Sturgill J, Zhou Z, Barbour S, Chalfant C, Conrad DH, Kepley CL. Norton SK, et al. Among authors: kepley cl. J Allergy Clin Immunol. 2012 Sep;130(3):761-769.e2. doi: 10.1016/j.jaci.2012.04.023. Epub 2012 Jun 2. J Allergy Clin Immunol. 2012. PMID: 22664166 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

70 results

Search Page

Filters